Systematic Financial Management LP Boosts Stake in AngioDynamics, Inc. (NASDAQ:ANGO)

Systematic Financial Management LP grew its holdings in AngioDynamics, Inc. (NASDAQ:ANGO - Free Report) by 4.6% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,521,065 shares of the medical instruments supplier's stock after acquiring an additional 110,719 shares during the period. Systematic Financial Management LP owned about 6.23% of AngioDynamics worth $23,093,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also modified their holdings of ANGO. Divisadero Street Capital Management LP purchased a new stake in shares of AngioDynamics during the 4th quarter worth $4,714,000. Segall Bryant & Hamill LLC lifted its position in shares of AngioDynamics by 55.3% during the 4th quarter. Segall Bryant & Hamill LLC now owns 1,415,156 shares of the medical instruments supplier's stock worth $12,963,000 after purchasing an additional 503,713 shares during the last quarter. Marshall Wace LLP lifted its position in AngioDynamics by 1,335.1% in the fourth quarter. Marshall Wace LLP now owns 476,824 shares of the medical instruments supplier's stock valued at $4,368,000 after acquiring an additional 443,598 shares during the last quarter. Nuveen Asset Management LLC lifted its position in AngioDynamics by 37.4% in the fourth quarter. Nuveen Asset Management LLC now owns 1,296,366 shares of the medical instruments supplier's stock valued at $11,875,000 after acquiring an additional 353,070 shares during the last quarter. Finally, Arrowstreet Capital Limited Partnership lifted its position in AngioDynamics by 293.9% in the fourth quarter. Arrowstreet Capital Limited Partnership now owns 352,544 shares of the medical instruments supplier's stock valued at $3,229,000 after acquiring an additional 263,034 shares during the last quarter. Institutional investors and hedge funds own 89.43% of the company's stock.

AngioDynamics Price Performance

Shares of NASDAQ:ANGO traded down $0.20 on Thursday, reaching $9.37. The company's stock had a trading volume of 183,231 shares, compared to its average volume of 552,423. The stock's 50-day moving average is $9.47 and its two-hundred day moving average is $9.44. AngioDynamics, Inc. has a 52-week low of $5.47 and a 52-week high of $13.50. The stock has a market capitalization of $380.45 million, a P/E ratio of -1.66 and a beta of 0.58.

AngioDynamics (NASDAQ:ANGO - Get Free Report) last announced its earnings results on Wednesday, April 2nd. The medical instruments supplier reported $0.03 EPS for the quarter, beating analysts' consensus estimates of ($0.13) by $0.16. AngioDynamics had a negative net margin of 79.38% and a negative return on equity of 7.26%. The business had revenue of $72.00 million during the quarter, compared to analysts' expectations of $70.30 million. AngioDynamics's revenue was down 4.3% compared to the same quarter last year. Equities analysts forecast that AngioDynamics, Inc. will post -0.37 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Separately, HC Wainwright reissued a "buy" rating and issued a $16.00 price target (up from $15.00) on shares of AngioDynamics in a research report on Monday, April 7th.

About AngioDynamics

AngioDynamics, Inc, a medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. The company offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium.